Above: Scott and Sally Harrison with children in Uganda, 2011


Scott and Sally Harrison

CURE Founders, Scott and Sally Harrison, 2010

CURE International comes straight from the hearts of its founders, Scott and Sally Harrison. It started with an invitation.

In 1986, Dr. Scott Harrison, a successful orthopaedic surgeon and international businessman, was asked to perform spine surgery and teach higher level orthopaedic surgical skills to local medical practitioners in Malawi. Over the years, he and Sally returned to Malawi on many occasions to help more and more children with disabilities. The stark realities of the physical and spiritual needs of these children haunted them, though. They saw that they were barely making a dent, and they wanted to do something about it.

The opportunity to do that came after Dr. Harrison’s tenure as CEO and President of Kirschner Medical, an international manufacturer of orthopaedic products, ended. In 1994, the company was merged with Biomet, and this gave the Harrisons the freedom and resources to pursue their passion for healing disabled children. In 1996, CURE International was founded and, two years later, CURE’s first hospital opened in Kenya.

Since 1998, CURE has established a presence in 14 countries. CURE hospitals have performed more than 213,800 procedures, more than 126,600 children have been treated at CURE clubfoot partner clinics, and surgeons trained by CURE have performed more than 15,000 procedures to treat hydrocephalus and spina bifida.

Under the leadership of Scott Harrison, CURE grew rapidly, opening new hospitals frequently and establishing two specialist programmes, CURE Clubfoot and CURE Neuro.

In 2012, the Harrisons passed the torch to a new leader, Dale Brantner, who had been serving CURE as a Senior Vice President. In 2016, leadership of the organization passed to long-time board member Roger Spoelman, who became interim President and CEO. CURE’s focus as an organization is now on growing deeper to bear more fruit, increasing the reach and capacity of the existing CURE network while remaining agile to take advantage of new opportunities for growth.